Overview
Hartmut Linde practices practicing medicine in Potsdam, Germany.
Their clinical expertise encompasses Small Lymphocytic Lymphoma (SLL), Chronic Lymphocytic Leukemia (CLL), Chronic B-Cell Leukemia (CBCL), and Leukemia.
They are actively involved in clinical research, co-authoring 10 peer reviewed articles.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Hartmut Linde
Is Hartmut Linde a top-rated expert for Small Lymphocytic Lymphoma (SLL)?
MediFind is an objective health platform that identifies experts based on real-world data. Hartmut Linde is classified as an Experienced expert for Small Lymphocytic Lymphoma (SLL), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Hartmut Linde participate in research or clinical trials?
Yes. Hartmut Linde has published 10 articles and abstracts on conditions like Small Lymphocytic Lymphoma (SLL). You can view a list of Hartmut Linde's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Chronic B-Cell Leukemia (CBCL)
- Chronic Lymphocytic Leukemia (CLL)
- LeukemiaLinde isExperienced. Learn about Leukemia.
- Pancreatic CancerLinde isExperienced. Learn about Pancreatic Cancer.
- Small Lymphocytic Lymphoma (SLL)